( September 10, 2026, 1:18 PM EDT) -- SAN FRANCISCO — Eli Lilly and Co. may proceed with a civil conspiracy theory against a pharmacy involved in providing compounded tirzepatide based on alleged violations of California’s unfair competition law (UCL) but cannot proceed with claims that the pharmacy and telehealth providers conspired to violate the Lanham Act, a California federal judge ruled in partially granting the defendants’ motion to dismiss....